These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33041187)

  • 1. Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities.
    Akkermans A; Chapsal JM; Coccia EM; Depraetere H; Dierick JF; Duangkhae P; Goel S; Halder M; Hendriksen C; Levis R; Pinyosukhee K; Pullirsch D; Sanyal G; Shi L; Sitrin R; Smith D; Stickings P; Terao E; Uhlrich S; Viviani L; Webster J
    Biologicals; 2020 Nov; 68():92-107. PubMed ID: 33041187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress and future directions for reduction, refinement, and replacement of animal use in veterinary vaccine potency and safety testing: a report from the 2010 NICEATM-ICCVAM International Vaccine Workshop.
    Stokes WS; Kulpa-Eddy J; Brown K; Srinivas G; McFarland R
    Dev Biol (Basel); 2012; 134():9-21. PubMed ID: 22888590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vaccines consistency approach project: an EPAA initiative.
    De Mattia F; Hendriksen C; Buchheit KH; Chapsal JM; Halder M; Lambrigts D; Redhead K; Rommel E; Scharton-Kersten T; Sesardic T; Viviani L; Ragan I
    Pharmeur Bio Sci Notes; 2015; 2015():30-56. PubMed ID: 26830158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3Rs implementation in veterinary vaccine batch-release testing: Current state-of-the-art and future opportunities. A webinar and workshop report.
    Viviani L; Balks E; Beken S; Brady AM; Clayton R; Cliquet F; Desmayanti L; Fragoeiro S; Hamtak TJ; John D; Jungbaëck C; Kalaivani M; Kross I; Lang C; Ria Isriyanthi NM; Mallet L; Milne C; Rubbrecht M; Siklódi B; Singh B; Srinivas GB; Stickings P; Stirling C; Sundram P; Szabó M; Thomas A; van den Berg M; Walker A; Philippe C; Vandeputte J
    Biologicals; 2023 Aug; 83():101695. PubMed ID: 37516084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The consistency approach for quality control of vaccines - a strategy to improve quality control and implement 3Rs.
    De Mattia F; Chapsal JM; Descamps J; Halder M; Jarrett N; Kross I; Mortiaux F; Ponsar C; Redhead K; McKelvie J; Hendriksen C
    Biologicals; 2011 Jan; 39(1):59-65. PubMed ID: 21277791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three Rs Approaches in the Production and Quality Control of Fish Vaccines.
    Midtlyng PJ; Hendriksen C; Balks E; Bruckner L; Elsken L; Evensen O; Fyrand K; Guy A; Halder M; Hawkins P; Kisen G; Romstad AB; Salonius K; Smith P; Sneddon LU
    Biologicals; 2011 Mar; 39(2):117-28. PubMed ID: 21371907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement, Reduction, Refinement - Animal welfare progress in European Pharmacopoeia monographs: activities of the European Pharmacopoeia Commission from 2007 to 2017.
    Lang C; Kolaj-Robin O; Cirefice G; Taconet L; Pel E; Jouette S; Buda M; Milne C; Charton E
    Pharmeur Bio Sci Notes; 2018; 2018():12-36. PubMed ID: 29845933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global harmonization of vaccine testing requirements: Making elimination of the ATT and TABST a concrete global achievement.
    Viviani L; Halder M; Gruber M; Bruckner L; Cussler K; Sanyal G; Srinivas G; Goel S; Kaashoek M; Litthauer D; Lopes da Silva AL; Sakanyan E; Aprea P; Jin H; Vandeputte J; Seidle T; Yakunin D
    Biologicals; 2020 Jan; 63():101-105. PubMed ID: 31699501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of pyrogenicity testing: Phasing out the rabbit pyrogen test. A meeting report.
    Cirefice G; Schütte K; Spreitzer I; Charton E; Shaid S; Viviani L; Rubbrecht M; Manou I
    Biologicals; 2023 Nov; 84():101702. PubMed ID: 37643507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential application of the consistency approach for vaccine potency testing.
    Arciniega J; Sirota LA
    Dev Biol (Basel); 2012; 134():135-9. PubMed ID: 22888606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and opportunities for the implementation of the Three Rs in Canadian vaccine quality control.
    Long ME; Griffin G
    Regul Toxicol Pharmacol; 2012 Aug; 63(3):418-25. PubMed ID: 22634245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge sharing to facilitate regulatory decision-making in regard to alternatives to animal testing: Report of an EPAA workshop.
    Ramirez T; Beken S; Chlebus M; Ellis G; Griesinger C; De Jonghe S; Manou I; Mehling A; Reisinger K; Rossi LH; van Benthem J; van der Laan JW; Weissenhorn R; Sauer UG
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):210-26. PubMed ID: 26188116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement, reduction or refinement of animal use in the quality control of veterinary vaccines: development, validation and implementation.
    van der Kamp MD
    Dev Biol Stand; 1996; 86():73-6. PubMed ID: 8785994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potency testing of veterinary vaccines for animals: the way from in vivo to in vitro. Workshop summary.
    Dev Biol (Basel); 2012; 134():149-52. PubMed ID: 22888608
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progress in the replacement of animal experiments in the quality control of clostridial vaccines].
    Cussler K; Borrmann E; Werner E
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):172-7. PubMed ID: 11998369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistency as tool to support in vitro batch potency testing in GMP production.
    Stirling C
    Dev Biol (Basel); 2012; 134():115-8. PubMed ID: 22888603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory Acceptance of Alternative Methods in the Development and Approval of Pharmaceuticals.
    Beken S; Kasper P; van der Laan JW
    Adv Exp Med Biol; 2016; 856():33-64. PubMed ID: 27671719
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Kulpa-Eddy J; Srinivas G; Halder M; Hill R; Brown K; Roth J; Draayer H; Galvin J; Claassen I; Gifford G; Woodland R; Doelling V; Jones B; Stokes WS
    Procedia Vaccinol; 2011; 5():60-83. PubMed ID: 32288914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three Rs potential in the development and quality control of immunobiologicals.
    Halder M
    ALTEX; 2001; 18 Suppl 1():13-47. PubMed ID: 11854853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refinement, reduction, and replacement of animal use for regulatory testing: future improvements and implementation within the regulatory framework.
    Richmond J
    ILAR J; 2002; 43 Suppl():S63-8. PubMed ID: 12388854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.